http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101482708-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 |
filingDate | 2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101482708-B1 |
titleOfInvention | Novel use of C-terminal domain of IGFBP-5 comprising heparin-binding domain as an angiogenesis inhibitor |
abstract | The present invention relates to a pharmaceutical composition for inhibiting angiogenesis, which comprises, as an active ingredient, a peptide comprising heparin-binding domain of IGFBP-5 (insulin-like growth factor-binding protein 5) A method for inhibiting angiogenesis, a pharmaceutical composition for preventing or treating cancer comprising the peptide as an active ingredient, a method for treating cancer using the peptide, a novel angiogenesis derived from the heparin-binding domain of IGFBP-5 Inhibitory peptides, polynucleotides encoding the peptides, vectors containing the polynucleotides, and transformants containing the vectors. |
priorityDate | 2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 559.